ALEMBICLTD.NS Stock Analysis
AL
Uncovered
Alembic Ltd is uncovered by Eyestock quantitative analysis.
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Market cap $B
0.108
Dividend yield
1.64 %
Shares outstanding
256.78 B
Alembic Ltd. engages in the pharmaceutical and real estate business. The company is headquartered in Vadodara, Gujarat and currently employs 271 full-time employees. The firm operates through a single segment, Pharmaceuticals. The Pharmaceuticals segment is engaged in the manufacturing and marketing of fermentation and chemistry-based Active Pharmaceuticals Ingredients (API). The firm is also engaged in research and development activity at Vadodara. The firm manufactures/provides three key products/services: Azithromycin, Venlafaxine and Telmisartan.